|
|||||
|
|
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19 |
|
| Authors: | Santiago Thibaud Douglas Tremblay Sheena Bhalla Brittney Zimmerman Keith Sigel Janice Gabrilove |
| Affiliation: | 1. Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;2. Division of Infectious Diseases, Icahn School of Medicine at Mount Sinaii, New York, NY, USA |
| Abstract: | |
| Keywords: | BTK inhibitors CLL COVID-19 |